Sarepta Therapeutics
SRPT
#5160
Rank
โ‚น165.27 B
Marketcap
โ‚น1,541
Share price
-4.81%
Change (1 day)
0.66%
Change (1 year)
Sarepta Therapeutics is an American medical research company dedicated to the discovery and development of precisely effective gene therapeutics for the treatment of rare neuromuscular diseases.

EPS for Sarepta Therapeutics (SRPT)

EPS in 2023 (TTM): -โ‚น644.46

According to Sarepta Therapeutics 's latest financial reports the company's current EPS (TTM) is -โ‚น247.00. In 2022 the company made an earnings per share (EPS) of -โ‚น754.16 a decrease over its 2021 EPS that were of -โ‚น483.68.

EPS history for Sarepta Therapeutics from 1997 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-โ‚น644.46-14.55%
2022-โ‚น754.1655.92%
2021-โ‚น483.68-27.16%
2020-โ‚น664.00-26.96%
2019-โ‚น909.1378.6%
2018-โ‚น509.04603.9%
2017-โ‚น72.32-85.9%
2016-โ‚น512.795.2%
2015-โ‚น487.4353.1%
2014-โ‚น318.38-0%
2013-โ‚น318.38-33.79%
2012-โ‚น480.867214.29%
2011-โ‚น6.57-96.11%
2010-โ‚น169.0515.38%
2009-โ‚น146.51-23.53%
2008-โ‚น191.59-37.04%
2007-โ‚น304.29-0%
2006-โ‚น304.2945.95%
2005-โ‚น208.50-46.38%
2004-โ‚น388.8240.82%
2003-โ‚น276.12-57.02%
2002-โ‚น642.40-2.56%
2001-โ‚น659.30138.78%
2000-โ‚น276.12-20.97%
1999-โ‚น349.37-72.2%
1998-โ‚น1,257519.44%
1997-โ‚น202.86

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Gilead Sciences
GILD
-โ‚น291.15 17.87%๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
-โ‚น46.02-81.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
-โ‚น142.76-42.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚น1,861-853.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Insmed
INSM
-โ‚น264.85 7.22%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-โ‚น135.24-45.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
-โ‚น392.58 58.94%๐Ÿ‡บ๐Ÿ‡ธ USA